Thursday, 22nd of September 2011 |
BMJ 2011; 343:d4888 doi: 10.1136/bmj.d4888 (Published 2 August 2011)
http://www.bmj.com/content/343/bmj.d4888.full?sid=2ae295f3-182b-47b5-adb0-642c149ba0ad
Cite this as: BMJ 2011; 343:d4888
Letter
Non-communicable disease
Why we should emphasise prevention over treatment of non-communicable disease
Richard Smith, director, UnitedHealth Chronic Disease Initiative1
+ Author Affiliations
1London SW4 0LD, UK
I sympathise with Heath’s anxiety about turning people into “patients” by identifying those at risk of developing non-communicable diseases (NCDs), but is she really advocating that we wait until people are “sick” and then have them looked after by doctors?1 She seems to argue for treatment rather than prevention.
Her thinking perhaps flows from an attachment to the medical model. She is surely not against policy interventions like raising taxes on alcohol and reducing salt intake, the “best buys” recommended by WHO.2 Most of the interventions advocated by WHO are nothing to do with doctors and health systems. Most of what needs to be done to counter NCDs lies outside the health system.
We have strong evidence that we can prevent prediabetes and prehypertension progressing to the full blown conditions by helping people change their lifestyles and lose weight.3 4 Again, this is nothing to do with doctors and drugs. The programmes are unaffordable if they use doctors rather than community health workers. Surely Heath is not suggesting that these people should be simply watched as they develop full blown disease.
There are difficult questions about how much countries should invest in policy changes, prevention, and treatment programmes. Heath’s thinking is the opposite of many in low and middle income countries. Our network of researchers from some of these countries thinks that the emphasis must be on prevention—because the Western model of emphasising treatment is unaffordable and unachievable when health workers are in such short supply.5
Cite this as: BMJ 2011;343:d4888
Competing interest: UnitedHealth together with the National Heart, Lung and Blood Institute funds and works with 11 centres in low and middle income countries that are doing research, training people, and developing policy to counter NCDs. Together with the Centers for Disease Control, UnitedHealth has developed a programme for preventing people with prediabetes developing diabetes.
References
Heath I. Seeming virtuous on chronic diseases. BMJ2011;343:d4239. (8 July.)
WHO. Global status report on noncommunicable disease 2010. 2011. www.who.int/chp/ncd_global_status_report/en/index.html.
Knowler W, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med2002;346:393-403.
[CrossRef][Medline][Web of Science]
McGuire HL, Svetkey LP, Harsha DW, Elmer PJ, Appel LJ, Ard JD. Comprehensive lifestyle modification and blood pressure control: a review of the PREMIER trial. J Clin Hypertens2004;6:383-90.
UnitedHealth, National Heart, Lung, and Blood Institute Centers of Excellence. Global response to non-communicable disease. BMJ2011;342:d3823.
Are three drugs for malaria better than two?
Friday, 24th of April 2020 |
Public health Interventions and epidemic intensity during the 1918 influenza pandemic
Thursday, 16th of April 2020 |
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Tuesday, 17th of March 2020 |
Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applications
Monday, 17th of February 2020 |
Immunization Agenda 2030
Tuesday, 11th of February 2020 |
41096923 |
www.measlesinitiative.org www.technet21.org www.polioeradication.org www.globalhealthlearning.org www.who.int/bulletin allianceformalariaprevention.com www.malariaworld.org http://www.panafrican-med-journal.com/ |